Rebecca Lownes Urbano
About Rebecca Lownes Urbano
Rebecca Lownes Urbano is the Associate Director of Analytical CMC Strategy at Bristol Myers Squibb, with extensive experience in bioengineering and pharmaceutical research.
Current Position at Bristol Myers Squibb
Rebecca Lownes Urbano is currently the Associate Director of Analytical CMC Strategy at Bristol Myers Squibb. In this role, she is responsible for overseeing the analytical lifecycle of pharmaceutical products from development through commercialization. Her work involves strategic planning and execution of analytical methods to ensure product quality and regulatory compliance.
Previous Roles at Bristol Myers Squibb
Rebecca has a robust history with Bristol Myers Squibb, having held several key positions. She served as a Senior Scientist in Analytical CMC Strategy from 2018 to 2021 and as a Senior Scientist in Methods Lifecycle (Bioassay/Immunoassay) from 2015 to 2018. In these roles, she contributed to the development and validation of analytic methods that are crucial for product integrity and regulatory submissions.
Educational Background
Rebecca earned her Ph.D. in Mechanical Engineering from Drexel University, where she conducted bioengineering research with a focus on cell-based potency bioassays. In addition to her doctoral degree, she holds both a BS and MS in Biomedical Engineering from Drexel University. Her extensive education has equipped her with foundational knowledge in bioassay techniques and engineering principles.
Professional Experience in Research and Development
Rebecca's career began with hands-on research roles, including positions at Merck and Janssen Pharmaceutical Companies of Johnson & Johnson. She has experience as a Staff Biologist at Merck from 2007 to 2011 and multiple co-op student roles at Janssen. Her time as a Graduate Research Assistant at Drexel University from 2011 to 2015 further honed her expertise in analytical and bioengineering research.
Technical Expertise and Skills
Rebecca possesses over eight years of experience in GLP and GMP laboratories, specializing in techniques such as flow cytometry, ELISA, cell viability, and reporter cell line assays. She is adept at international technical transfer, release and stability testing of therapeutic proteins, analyst training and qualification, and assay development and validation. Her doctoral training focused on cell-based potency bioassays, enhancing her technical skill set.